• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ultralife Corporation to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

    12/4/24 5:00:16 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ULBI alert in real time by email

    NEWARK, N.Y., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI), today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.

    The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Ultralife will be participating in one-on-one meetings with investors and analysts throughout the day.

    To schedule a one-on-one meeting with Ultralife, you may submit your request online via the registration link provided. To register for the conference, please visit https://www.meetmax.com/sched/event_112571/investor_reg_new.html?attendee_role_id=INVESTOR

    About The Benchmark Company

    The Benchmark Company is an institutionally focused, research driven, sales trading and investment banking firm. We were founded in 1988 and are headquartered in New York City. Our focus is on fostering the long-term success of our corporate clients through raising capital, providing strategic advisory services, generating insightful research, and developing institutional sponsorship by leveraging the firm's sales, trading, and equity research capabilities. https://www.benchmarkcompany.com.

    About Ultralife Corporation

    Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government/defense and commercial customers across the globe. Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

    Contacts:           
       
    Company Contact:

    Ultralife Corporation

    Philip A. Fain

    (315) 210-6110

    [email protected]

     Investor Relations Contact:

    Alliance Advisors IR

    Jody Burfening/Alex Villalta

    (917) 972-3253

    [email protected]
       


    Primary Logo

    Get the next $ULBI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What event will Ultralife Corporation be participating in?

      Ultralife Corporation will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference.

    • When and where will the conference take place?

      The conference is scheduled for Wednesday, December 11th, 2024, at the New York Athletic Club in New York City.

    • What type of meetings will Ultralife hold during the conference?

      Ultralife will participate in one-on-one meetings with investors and analysts throughout the day at the conference.

    • How can investors schedule a meeting with Ultralife?

      Investors can schedule a one-on-one meeting with Ultralife by submitting a request online through a provided registration link.

    • What is The Benchmark Company and what services do they provide?

      The Benchmark Company is a research-driven investment banking firm that focuses on fostering long-term success for its corporate clients through capital raising and strategic advisory services.

    Recent Analyst Ratings for
    $ULBI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ULBI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Whitmore Bradford T bought $1,196,909 worth of shares (187,512 units at $6.38) (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    3/16/26 4:25:31 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Manna Michael Edward bought $12,024 worth of Ultralife Common Stock; $.10 par value (2,000 units at $6.01), increasing direct ownership by 8% to 26,874 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    3/16/26 4:13:07 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 4 filed by Director Whitmore Bradford T

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    1/5/26 7:56:31 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ultralife Corporation Reports Fourth Quarter Results

    NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarterGross profit of $12.1 million, or 24.9% of revenue, compared to $10.6 million, or 24.2% of revenue, for the 2024 fourth quarterOperating (loss) income of ($10.6) million, which includes a ($12.2) million intangible asset impairment charge and ($1.2) million of one-time costs, compared to $1.5 million for the 2024 fourth quarterGAAP EPS of ($0.45), which includes ($0.57) for the intangible asset impairment charge net

    3/10/26 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation to Report Fourth Quarter Results on March 10, 2026

    NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its fourth quarter results for the period ending December 31, 2025 before the market opens on Tuesday, March 10, 2026. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on March 10, 2026. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BIf9df949a927a4356820e8cfb1becccdc.

    3/5/26 4:05:00 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation Reports Third Quarter Results

    NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem, sales of $36.6 million increased 2.5%Gross profit of $9.6 million, or 22.2% of revenue, compared to $8.7 million, or 24.3% of revenue, for the third quarter of 2024Operating loss of $1.0 million, reflecting one-time non-recurring costs of $1.1 million, including a $.5 million provision to close our Calgary facility, compared to operating income of $0.5 million for the third quarter of 2024GAAP EP

    11/18/25 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Whitmore Bradford T bought $1,196,909 worth of shares (187,512 units at $6.38) (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    3/16/26 4:25:31 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Manna Michael Edward bought $12,024 worth of Ultralife Common Stock; $.10 par value (2,000 units at $6.01), increasing direct ownership by 8% to 26,874 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    3/16/26 4:13:07 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Director Whitmore Bradford T bought $300,902 worth of shares (53,000 units at $5.68) (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    12/16/25 4:32:26 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Benchmark initiated coverage on Ultralife with a new price target

    Benchmark initiated coverage of Ultralife with a rating of Buy and set a new price target of $12.00

    3/26/21 8:30:50 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    The Benchmark Company initiated coverage on Ultralife with a new price target

    The Benchmark Company initiated coverage of Ultralife with a rating of Buy and set a new price target of $12.00

    3/26/21 7:38:12 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    SEC Filings

    View All

    SEC Form 10-K filed by Ultralife Corporation

    10-K - ULTRALIFE CORP (0000875657) (Filer)

    3/23/26 4:01:45 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ULTRALIFE CORP (0000875657) (Filer)

    3/10/26 5:25:08 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ULTRALIFE CORP (0000875657) (Filer)

    11/18/25 7:30:23 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Ultralife Corporation

    SC 13D/A - ULTRALIFE CORP (0000875657) (Subject)

    9/3/24 4:15:14 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Ultralife Corporation

    SC 13G - ULTRALIFE CORP (0000875657) (Subject)

    2/14/24 1:50:40 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Ultralife Corporation (Amendment)

    SC 13G/A - ULTRALIFE CORP (0000875657) (Subject)

    2/9/24 9:59:17 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Financials

    Live finance-specific insights

    View All

    Ultralife Corporation Reports Fourth Quarter Results

    NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarterGross profit of $12.1 million, or 24.9% of revenue, compared to $10.6 million, or 24.2% of revenue, for the 2024 fourth quarterOperating (loss) income of ($10.6) million, which includes a ($12.2) million intangible asset impairment charge and ($1.2) million of one-time costs, compared to $1.5 million for the 2024 fourth quarterGAAP EPS of ($0.45), which includes ($0.57) for the intangible asset impairment charge net

    3/10/26 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation to Report Fourth Quarter Results on March 10, 2026

    NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its fourth quarter results for the period ending December 31, 2025 before the market opens on Tuesday, March 10, 2026. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on March 10, 2026. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BIf9df949a927a4356820e8cfb1becccdc.

    3/5/26 4:05:00 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation Reports Third Quarter Results

    NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem, sales of $36.6 million increased 2.5%Gross profit of $9.6 million, or 22.2% of revenue, compared to $8.7 million, or 24.3% of revenue, for the third quarter of 2024Operating loss of $1.0 million, reflecting one-time non-recurring costs of $1.1 million, including a $.5 million provision to close our Calgary facility, compared to operating income of $0.5 million for the third quarter of 2024GAAP EP

    11/18/25 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Leadership Updates

    Live Leadership Updates

    View All

    Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans

    NEWARK, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) today announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing our corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with our sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife's products and solutions meet the evolving needs of our customers. Jeff brings over two

    1/6/25 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation Names Michael E. Manna President & CEO

    NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation ("Ultralife" or the "Company") (NASDAQ:ULBI) has appointed Michael E. Manna as the Company's President & CEO and as a member of the Board of Directors effective immediately to replace Michael D. Popielec who is leaving the Company. Mr. Popielec will remain with Ultralife as an employee for a sixty-day period ending January 20, 2023 in an advisory role to ensure a smooth leadership transition. In addition to his new role, Mike Manna will retain his leadership position for the Company's Battery & Energy Products segment which he held prior to his appointment as President & CEO. "Over the past twe

    11/22/22 4:30:00 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous